Successful management of a critically ill burn patient suffering sepsis by use of endotoxin absorption therapy (PMX)

Burns

Volumn 30, Issue 3, 2004, Pages 276-279

  Nakazawa, Hiroaki ^a   Kikuchi, Yuji ^a   Honda, Takashi ^a   Isago, Tsukasa ^a   Nozaki, Motohiro ^a   Morioka, Kosuke ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b K   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BURN; CASE REPORT; CLINICAL FEATURE; CRITICAL ILLNESS; DISEASE COURSE; ENDOTRACHEAL INTUBATION; ENTEROBACTER CLOACAE; HUMAN; LABORATORY TEST; MALE; RESUSCITATION; SEPSIS;

ABSORPTION; BURNS; CRITICAL ILLNESS; ENDOTOXINS; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 1842735228     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2003.10.014     Document Type: Article

References (14)

1. Aoki H., Kodama M., Tani T., Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am. J. Surg. 167:1994;412-417.
2. Tani T., Hanazawa K., Endo Y., Kodama M. The efficiency and limit of endotoxin absorbing therapy on the multiple organ failure. ICU&CCU. 19:1995;797-804.
3. Shimaoka H., Nakada K., Atagi K., Nakasuji M., Takaki O., Satani M. The efficacy of endotoxin absorbing therapy. ICU&CCU. 20:1996;693-698.
4. Shoji H., Tani T., Hanasawa K., Kodama M. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. Ther. Apheresis. 2:1998;3-12.
5. Tsuruzono K., Inoue K., Harunari N., Yamashita K., Mega K., Ueyama M. Endotoxin absorption therapy for extensively burned patients. ICU&CCU. 24:2000;913-919.
6. Fujita N., Mouri T., Yamashita T., Itoh E., Sugihara M., Hirahara K. The mechanism of efficacy of endotoxin absorption. ICU&CCU. 24:2000;881-889.
7. Shinozawa Y., Takuma K., Aikawa N. Sepsis in extensive burned patients. J. Jpn. Surg. Soc. 99:1998;31-39.
8. Ogata M. The mechanism of organ dysfunction due to endotoxin. Intensive Crit. Care Med. 11:1999;135-141.
9. Maruyama S. Endotoxin shock. ICU&CCU. 24:2000;865-874.
10. Ikeda T., Ikeda K., Onizuka T., Suzuki H., Suzuki K., Ohashi H. When should we consider blood absorption therapy using polymyxin B-immobilized fibers for septic shock patients? ICU&CCU. 24:2000;891-897.
11. Hanazawa K., Kodama M., Tani M. Endotoxin absorption therapy - recent study and its advancement. Intensive Crit. Care Med. 11:1999;161-168.
12. Aikawa N., Fujishima S., Shinozawa Y., Hori S. Cytokine mediated biological response to sever infections in surgical patients. J. Jpn. Surg. Soc. 97:1996;1054-1059.
13. Kanesaka S., Takahashi Y. Endotoxin absorption as therapeutic strategy for systemic inflammatory response syndrome. Jpn. J. Acute Med. 20:1996;1111-1115.
14. Barriere S.L., Lowry S.F. An overview of mortality risk prediction in sepsis. Crit. Care Med. 23:1995;376-393.